My 3 Favorite Vanguard ETFs to Buy Right Now
Axe Capital view
Vanguard ETFs: Solid US Exposure with Local Eyes
Three Vanguard ETFs can add US growth and income plays to South African portfolios, but weigh currency risk carefully.
South African investors looking to diversify beyond the JSE often turn to US equities. Vanguard’s VTI ETF offers broad exposure to the entire US stock market—including mid and small caps—at a rock-bottom cost. It’s a simple way to own American growth and value in one product. Then there’s VIG, which focuses on companies with over a decade of rising dividends. That dividend discipline tends to mean stable earnings, less volatility—a quality anchor when emerging market jitters hit. Meanwhile, VONG is a more aggressive growth play, leaning into sectors like tech and consumer discretionary that can deliver higher total returns over time but with more bumps along the way. For South Africans, currency risk matters. The rand’s swings against the dollar will impact overall returns, so adding these US ETFs should come with a view on USD/ZAR trends. If the rand suddenly strengthens or weakens sharply, gains from the US market can evaporate or multiply. Watch the rand and blend these ETFs with strong JSE names like Naspers or MTN for more direct local growth. This combination balances stable income, growth, and currency hedges. If US markets cool off or changes to dividend policies arise, these ETFs could underperform local peers in the short term. this is just my opinion and not financial advice
Buy VTI and VIG as core US exposure while trimming VONG for now due to its higher risk and volatility. Keep an eye on USD/ZAR and scale local shares like Naspers to balance currency exposure.
- VTI
- VIG
- USD/ZAR
- Naspers
- Rand volatility undermining foreign returns
- US market correction affecting growth stocks
6/10
The article recommends three Vanguard ETFs for a diversified portfolio: VTI (Vanguard Total Stock Market ETF) as the core foundation providing comprehensive U.S. stock market exposure including mid and small-caps; VIG (Vanguard Dividend Appreciation ETF) for conservative growth focused on dividend-paying companies with 10+ years of consecutive dividend growth; and VONG (Vanguard Russell 1000 Growth ETF) as the aggressive growth component emphasizing high total return potential. Together, these ETFs provide a balanced approach to long-term investing, though the author notes they should be supplemented with small-cap, international, and bond exposure.
This article was originally published by The Motley Fool and has been adapted here for Axe Capital Trading News.
Publisher: The Motley Fool
Author: David Dierking
Categories: Rates, Equities, Capital Returns
Tickers: VTI, VIG, VONG
Sentiment: Positive - Recommended as the core foundation of a diversified portfolio with comprehensive U.S. stock market exposure including large, mid, and small-cap stocks. Low expense ratio (0.03%) and strong AUM ($2.3T) support its selection. Recommended as the conservative growth component focusing on financially healthy companies with 10+ years of consecutive dividend growth. Provides income and quality with a reasonable expense ratio (0.04%).
Keywords: ETF, portfolio diversification, dividend growth, growth investing, long-term investing, U.S. stock market
Insights:
- VTI: Positive: Recommended as the core foundation of a diversified portfolio with comprehensive U.S. stock market exposure including large, mid, and small-cap stocks. Low expense ratio (0.03%) and strong AUM ($2.3T) support its selection.
- VIG: Positive: Recommended as the conservative growth component focusing on financially healthy companies with 10+ years of consecutive dividend growth. Provides income and quality with a reasonable expense ratio (0.04%).
- VONG: Positive: Recommended as the aggressive growth counterpart offering higher return potential through exposure to large and mid-cap growth stocks. Provides more diversification than large-cap only alternatives.
Related coverage
- Which ETF Is Healthier for Your Portfolio: Vanguard Health Care ETF or iShares Pharmaceuticals ETF?
- GM Raised Its 2026 Profit Outlook to as Much as $16 Billion -- the Second Raise This Year. Here's the Part of the Business That Turned.
- SharkNinja CEO Mark Barrocas Sells $38.8 Million Stock -- Should Investors Take Action?